Scott Kopetz, MD
M.D. Anderson Cancer Center · MD Anderson
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Scott Kopetz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:42 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT07318389 · ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal CancerM.D. Anderson Cancer Center · recruiting · Dynamic Tumor Resistance, Metastatic Colorectal Cancer · principal investigator
- N/ANCT05292859 · Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsAlaunos Therapeutics · completed · Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer · principal investigator
- Ph1/Ph2NCT05194735 · Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsAlaunos Therapeutics · terminated · Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer · principal investigator
- N/ANCT05124743 · HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsAlaunos Therapeutics · terminated · Ovarian Cancer, Endometrial Cancer, Colo-rectal Cancer · principal investigator
- Ph2NCT03549338 · Sym004 Versus Futuximab or Modotuximab in Patients With mCRCSymphogen A/S · terminated · Metastatic Colorectal Cancer, Colorectal Cancer Metastatic, Carcinoma · principal investigator
- N/ANCT01196130 · Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening ProtocolM.D. Anderson Cancer Center · completed · Colorectal Cancer · principal investigator
- Ph1NCT00501410 · FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal CancerM.D. Anderson Cancer Center · completed · Colorectal Cancer · principal investigator
- Ph2NCT00354978 · Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer PatientsM.D. Anderson Cancer Center · completed · Colorectal Cancer · principal investigator
- Ph3NCT00305643 · Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal CancerM.D. Anderson Cancer Center · terminated · Breast Cancer, Colorectal Cancer, Pain · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Stress Signaling Pathways and Resistance in Colorectal CancerR01CA172670 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · fiscal years 2013 to 2017Named on NCT01196130
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in colorectal cancer.